Concepedia

Author

Kaoru Yamagami

Astellas Pharma (Japan)

Also Known As

K. Yamagami, Kaoru Yamagami, Yamagami, K., Yamagami, Kaoru

20

Publications

184

Citations

6

H-Index

24

Concepts

All Affiliations

Astellas Pharma (Japan)
KY

About

Kaoru Yamagami is an author at Astellas Pharma (Japan) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

140

2

Engineering

1

1

13

3

Natural Sciences

1

1

15

4

Allergy

1

1

11

5

Applied Physics

1

1

13

Kaoru Yamagami

×

6

Publications

165

Citations

6

H-Index

YearCitations

A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model

Misato Ito, Shunji Yamazaki, Kaoru Yamagami,

Journal of Pharmacological Sciences

2016

91

Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor

Junko Imanishi, Yoshiaki Morita, Eiji Yoshimi,

Biochemical Pharmacology

2011

23

Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors

Toshihiro Hamajima, Fumie Takahashi, Koji Kato,

Bioorganic & Medicinal Chemistry

2018

15

[2+2] photodimerization of (E)-styrylthiazoles through cation–π-controlled preorientation

Shinji Yamada, Kaoru Yamagami, Saki Oaku

Tetrahedron Letters

2016

13

THU0101 ASP015K: A Novel Jak Inhibitor Demonstrated Potent Efficacy in Adjuvant-Induced Arthritis Model in Rats

S. Yamazaki, Hiroki Morio, Masamichi Inami,

Annals of the Rheumatic Diseases

2013

12

Effect of FK3657, a non-peptide bradykinin B2 receptor antagonist, on allergic airway disease models

Yoshitaka Hirayama, Kikuo Miyayasu, Kaoru Yamagami,

European Journal of Pharmacology

2003

11

Page 1